ABOUT SBISystems Biology Ireland (SBI), a Science Foundation Ireland Centre for Science Engineering and Technology (CSET), is a research initiative between University College Dublin and the National University of Ireland, Galway. SBI was established in June 2009 and has research facilities on both the Belfield and NUIG campuses.
Led by Profs Walter Kolch and Boris Kholodenko, the SBI CSET is funded by Science Foundation Ireland and its industrial partners: Agilent Technologies, Ark Therapeutics, Hewlett Packard, Protagen AG, Servier and Siemens Ireland. Additional funding has been successfully obtained from two SBI co-coordinated EU FP7 Health proposals: ASSET & PRIMES. In addition, SBI has recently received funding from the HEA PRTLI 5 for new facilities which are
due for completion in 2013.
SBI combines modern biomedical technologies and mathematical / computational modelling to analyse, understand, predict and eventually manipulate the behaviour of complex biological systems. SBI focuses on the development of predictive mathematical models for intracellular signal transduction networks of:
SBI's research is applied to therapies in the fields of cancer, inflammatory diseases and mesenchymal stem cells (with Remedi, NUIG).
Deciphering the Networks of Life
Featured Academics
